Results 81 to 90 of about 21,658 (229)

The use of repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS) to relieve pain

open access: yes, 2019
Chronic pain resulting from injury of the peripheral or central nervous system may be associated with a significant dysfunction of extensive neural networks.
Fregni, Felipe   +5 more
core   +1 more source

High Definition Transcranial Direct Current Stimulation Does Not Modulate Implicit Task Sequence Learning and Consolidation [PDF]

open access: yes, 2019
The incidental acquisition of a succession of tasks is termed implicit task sequence learning. Patients with dorsolateral prefrontal cortex (DLPFC) lesions are strongly impaired in this ability. However, recent results of conventional transcranial direct
Meier, Beat   +2 more
core   +1 more source

Does the Longer Application of Anodal-Transcranial Direct Current Stimulation Increase Corticomotor Excitability Further? A Pilot Study

open access: yesBasic and Clinical Neuroscience, 2012
Introduction: Anodal transcranial direct current stimulation (a-tDCS) of the primary motor cortex (M1) has been shown to be effective in increasing corticomotor excitability.Methods: We investigated whether longer applications of a-tDCS coincide with ...
Shapour Jaberzadeh   +2 more
doaj   +2 more sources

Non-Invasive Brain Stimulation for Enhancement of Corticospinal Excitability and Motor Performance

open access: yesBasic and Clinical Neuroscience, 2013
During the past .. years, non-invasive .rain stimulation has .ecome an emerging .eld in clinical neuroscience due to its capability to transiently modulate corticospinal excitability, motor and cognitive functions.
Shapour Jaberzadeh, Maryam Zoghi
doaj  

Rebooting the Brain: Non Invasive Brain Stimulation and the Future of Neurorehabilitation

open access: yesJournal of the Pakistan Medical Association
Non-Invasive Brain Stimulation (NIBS) is an emerging technology in neurorehabilitation with potential benefits to promote the neuroplasticity and functional recovery. This mini-review aims to summarize the recent clinical evidence evaluating the role of
Mehwish Anjum   +3 more
doaj   +1 more source

Innovations in Obesity Treatment: Beyond Adipose Tissue Dysfunction

open access: yesObesity Reviews, EarlyView.
Obesity drives chronic inflammation, insulin resistance, type 2 diabetes, and cancer development through adipocyte dysfunction. Addressing this multisystemic disorder requires integrated strategies beyond diet and exercise, such as thermogenesis activation via menthol or capsinoids and appetite control through GLP‐1/GIP agonists and neuromodulation to ...
Jesica Martínez‐Godfrey   +7 more
wiley   +1 more source

Neuronavigated focalized transcranial direct current stimulation administered during functional magnetic resonance imaging

open access: yes
Transcranial direct current stimulation (tDCS) is a noninvasive brain stimulation technique that allows the modulation of the excitability and plasticity of the human brain.
Hunold, A.   +18 more
core   +1 more source

Transcranial Electric Current Stimulation During Associative Memory Encoding: Comparing tACS and tDCS Effects in Healthy Aging [PDF]

open access: yes, 2020
Associative memory is one of the first cognitive functions negatively affected by healthy and pathological aging processes. Non-invasive brain stimulation (NIBS) techniques are easily administrable tools to support memory.
Wyss, Patric   +3 more
core   +1 more source

Temporal Interference Stimulation Enhances Neural Regeneration

open access: yesAdvanced Science, Volume 13, Issue 37, 3 July 2026.
Temporal interference (TI) stimulation is proposed as a non‐invasive approach to enhance neural regeneration in the deep brain. Theta‐band TI modulation selectively promotes neural progenitor cell differentiation in vitro and augments hippocampal neurogenesis in amouse model of Alzheimer's disease‐like amyloidosis.
Sofia Peressotti   +15 more
wiley   +1 more source

Efficacy of Low‐Dose Naltrexone in Women With Fibromyalgia Syndrome: A 12‐Month Randomised, Double‐Blind, Placebo‐Controlled Single‐Centre Clinical Trial (INNOVA Study)

open access: yesEuropean Journal of Pain, Volume 30, Issue 6, July 2026.
ABSTRACT Background Low‐dose naltrexone (LDN) has been used off‐label for fibromyalgia syndrome (FMS) for over a decade, supported by small crossover trials. The INNOVA study evaluated the safety and efficacy of LDN 4.5 mg versus placebo on pain intensity over 12 months in women with FMS.
Carla Rodríguez‐Freire   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy